Development of a Cloud-Based PRO (Patient-Reported Outcome) Management Program for Home-Based Cancer Pain Care

4th Affiliated Hospital, School of Medicine, Zhejiang University, China

Status

Withdrawn

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07308223

Enrollment

Registered

2025-12-29

Start date

2026-01-01

Completion date

2026-03-23

Last updated

2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain

Brief summary

This study aims to develop and pilot a cloud-based Patient-Reported Outcomes (PROs) management program for home-based cancer pain patients within a hospital setting. It is expected to serve as a reference for improving pain management in home-based cancer care and to provide insights for future related research as well as the broader application and dissemination of the program.

Interventions

OTHERProactive monitoring and patient education

The intervention featured proactive monitoring of PRO data with threshold-based alerts, coupled with personalized patient education via the cloud and follow-up calls, to enhance timely care and self-management.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Aged 18 years or older; Pathologically confirmed diagnosis of cancer with concomitant pain requiring analgesic medication; Alert and oriented, free of psychiatric disorders or cognitive impairment; Adequate comprehension, essentially normal vision and hearing, and basic literacy; Proficient in using a smartphone (patient or primary caregiver), willing to accept cloud-platform follow-up and participate throughout the study; Informed consent and voluntary participation.

Exclusion criteria

Presence of severe psychiatric disorders; Critically ill or debilitated patients with advanced-stage tumor who are unable to complete the study procedures. Withdrawal Criteria: Voluntary withdrawal or failure to complete the entire study process; Death during follow-up; Occurrence of accidents or clinical deterioration rendering continued participation infeasible; Request to withdraw for any reason.

Design outcomes

Primary

Measure	Time frame	Description
pain intensity	1 month	Use the Numerical Rating Scale (NRS) to assess pain intensity, with scores ranging from 0 to 10, where a higher number indicates more severe pain.

Secondary

Measure	Time frame	Description
Medication adherence	1 month	Morisky questionnaire on medication adherence, with scores ranging from 0 to 8; a higher score indicates better medication adherence.

Countries

China

Contacts

STUDY_DIRECTORHuafang Zhang, MSN